
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1081 | 1069 | 1144 | 1031 | 1276 | 2227 |
Fund Return | 8.11% | 6.9% | 14.37% | 1.03% | 4.99% | 8.34% |
Place in category | 455 | 175 | 177 | 464 | 277 | 31 |
% in Category | 60 | 23 | 26 | 81 | 58 | 9 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Framlington Switzerland A Capitalic | 284.02M | 8.03 | 0.27 | 7.53 | ||
Framlington Switzerland A Distribuc | 284.02M | 8.04 | 0.28 | 7.53 | ||
Framlington Switzerland F Capitalis | 284.02M | 8.11 | 1.03 | 8.34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.79B | 8.58 | 4.10 | 7.54 | ||
Pictet CH Institutional Swiss EquiI | 2.26B | 8.86 | 2.05 | 8.05 | ||
Pictet CH Institutional Swiss EquZD | 2.26B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiP | 2.26B | 8.84 | 1.85 | 7.84 | ||
UBS CH Equity Fund Swiss Income CHF | 2.54B | 8.29 | 0.69 | 5.71 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 7.26 | 294.70 | -0.07% | |
Nestle | CH0038863350 | 6.05 | 82.50 | +0.15% | |
Julius Baer | CH0102484968 | 5.71 | 58.66 | -2.20% | |
Novartis | CH0012005267 | 4.36 | 96.59 | +0.44% | |
Lonza Group | CH0013841017 | 4.02 | 580.00 | -0.92% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review